Wenju Peng
Overview
Explore the profile of Wenju Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang M, Wei J, Li P, Zhou Y, Li Y, Peng W, et al.
Materials (Basel)
. 2024 Dec;
17(23).
PMID: 39685188
The periodic changes in climatic factors cause the pavement temperature field to change significantly, resulting in fatigue damage to the pavement caused by temperature stress, and the influence depth has...
2.
Zhang Y, Yang W, Zhu Z, Zhang L, Peng W
Molecules
. 2024 Aug;
29(15).
PMID: 39124993
In this work, a series of thermosensitive ionic liquid functionalized polymers, PN(IL), with controllable morphology and particle size were prepared by free radical polymerization. Then, using the polymer PN(IL) with...
3.
Peng W, Lu T, Peng W, Wang Z
Sci Rep
. 2024 Aug;
14(1):18009.
PMID: 39097638
File sharing, being the foundation of the Internet, has traditionally relied on a centralized service architecture resulting in significant maintenance costs. Moreover, due to the lack of an effective file...
4.
Shan W, Peng W, Chen Y, Wang Y, Yu Q, Tian Y, et al.
Oncogene
. 2024 Apr;
43(25):1885-1899.
PMID: 38664501
Receptor-interacting protein kinase 4 (RIPK4) is increasingly recognized as a pivotal player in ovarian cancer, promoting tumorigenesis and disease progression. Despite its significance, the posttranslational modifications dictating RIPK4 stability in...
5.
Hu Z, Wu Z, Liu W, Ning Y, Liu J, Ding W, et al.
Nat Genet
. 2024 Apr;
56(4):637-651.
PMID: 38565644
Endometrial carcinoma remains a public health concern with a growing incidence, particularly in younger women. Preserving fertility is a crucial consideration in the management of early-onset endometrioid endometrial carcinoma (EEEC),...
6.
Hu X, Yan E, Peng W, Zhou Y, Jin L, Qian K
Acta Obstet Gynecol Scand
. 2024 Jan;
103(5):884-896.
PMID: 38217337
Introduction: Previous studies have demonstrated that abnormal body mass index (BMI) is associated with adverse pregnancy outcomes in frozen-thawed embryo transfer cycles. However, the relationship between BMI and pregnancy and...
7.
Li K, Chen J, Hu Y, Wang Y, Shen Y, Chen G, et al.
Lancet Oncol
. 2023 Dec;
25(1):76-85.
PMID: 38048802
Background: Locally advanced cervical cancer constitutes around 37% of cervical cancer cases globally and has a poor prognosis due to limited therapeutic options. Immune checkpoint inhibitors in the neoadjuvant setting...
8.
Fan J, Lu F, Qin T, Peng W, Zhuang X, Li Y, et al.
Nat Genet
. 2023 Nov;
55(12):2175-2188.
PMID: 37985817
Cervical squamous cell carcinoma (CSCC) exhibits a limited response to immune-checkpoint blockade. Here we conducted a multiomic analysis encompassing single-cell RNA sequencing, spatial transcriptomics and spatial proteomics, combined with genetic...
9.
Fu Y, Yang B, Cui Y, Hu X, Li X, Lu F, et al.
J Immunother Cancer
. 2023 Apr;
11(4).
PMID: 37072347
Background: Mismatch repair deficiency (dMMR) is a well-recognized biomarker for response to immune checkpoint blockade (ICB). Strategies to convert MMR-proficient (pMMR) to dMMR phenotype with the goal of sensitizing tumors...
10.
Jin H, Yan E, Chen D, Zhao M, Peng W, Guo Y, et al.
J Ovarian Res
. 2023 Apr;
16(1):77.
PMID: 37061732
Background: Previous studies have discussed the pregnancy outcomes of diminished ovarian reserve (DOR) patients. However, data on embryonic development potential, neonatal outcomes, and maternal complications of DOR patients still remained...